• Members Area (login)
  • Contact Us
  • Twitter
  • LinkedIn
Pharmabiotic Research Institute (PRI)
    • PRI
      • Home
      • Purpose & People
      • Representation
      • Partnerships
      • Task Groups
      • Members
      • Pharmabiotics Conference
      • Join PRI
    • Microbiome
      • Microbiome Science
      • Regulatory Status
      • Microbiome-based Medicinal Products
    • Regulatory Science
      • EU Landscape
      • Regulatory Framework
      • Regulatory Science & Tools
    • Insights
      • News & Events
      • PRI Publications
      • Member Job Openings
      • Members Area
Select Page
Galileo Research

Galileo Research

by Camille Bello | Nov 25, 2025 | Microbiome Pre-Clinical Research (CRO), Microbiome Clinical Research (CRO)

Silvia Trasciatti Chief Scientific Officer Galileo Research is specialized in non-clinical Discovery and Development services for the LifeSciences sector. Their expertise empowers companies in the pharmaceutical, medical device,novel foods, and dietary supplements...
Voisin Consulting Life Sciences (VCLS)

Voisin Consulting Life Sciences (VCLS)

by PRI | May 16, 2023 | Microbiome Clinical Research (CRO), Other Expertise | Quality, Legal, IP, Regulatory Affairs, Management

Clara Desvignes Director, Drugs, Medical Devices & Microbiome-based products VCLS collaborates with developers to strategically position their microbiome-based products, creating a roadmap to hit product development milestone, and achieve the commercial success....
Biofortis

Biofortis

by PRI | Jun 17, 2022 | Microbiome Analysis Expertise (service provider), Microbiome Clinical Research (CRO)

Benoit Fouchaq CEO Biofortis is a unique full services CRO providing Nutrition Clinical Trials, Microbiome Investigation and Data Science for Human and Animal Health....
Atlantia Clinical Trials

Atlantia Clinical Trials

by PRI | Jun 17, 2022 | Microbiome Clinical Research (CRO)

We are a world-class provider of human clinical studies. We perform acute, observational, PK/PD, pivotal, efficacy, and intervention studies to ICH-GCP standards for microbiome products.     ...

Recent News & Events

  • Shaping the future of European biotechnology: PRI’s response to the EU Biotech Act Call for Evidence
  • PRI welcomes Camille Bello as Communication and Membership Manager
  • PRI Board of Director members elects Eleni Tsompanidou as New President
  • Microbiome-based Biomarkers – a multidisciplinary Delphi consensus (The Lancet Microbe)
  • 2024 Pharmabiotics Conference & Partnering – Lille

– Legal Notices –
© PRI 2022. All rights reserved. Copy prohibited unless explicitly authorized. Please contact the PRI.

Pharmabiotic Research Institute (PRI) | European Microbiome Regulatory Science Center
Non-Profit Association (loi 1901) – 1 bis, rue Sénateur Emile Roux, 11100 Narbonne, France

Agence de communication : Frelonbleu